Pediatric tuberculosis: global overview and challenges

Swaminathan, Soumya ; Rekha, Banu (2010) Pediatric tuberculosis: global overview and challenges Clinical Infectious Diseases, 50 (s3). S184-S194. ISSN 1058-4838

Full text not available from this repository.

Official URL: https://academic.oup.com/cid/article-lookup/doi/10...

Related URL: http://dx.doi.org/10.1086/651490

Abstract

Tuberculosis (TB) is among the top 10 causes of death among children worldwide; however, children with TB are given low priority in most national health programs and are neglected in this epidemic. Recent technological advancements in diagnosis of TB in adults have not been validated in children. Similarly, trials of new drugs and development of pediatric formulations of standard first- and second-line drugs are lagging behind. Among human immunodeficiency virus (HIV)-coinfected children, the optimal timing for highly active antiretroviral therapy initiation and drug combinations that have minimal interactions with anti-TB drugs need further study. Although bacille Calmette-Guérin vaccine, the only vaccine available for TB, protects against disseminated and severe forms of the disease in young children, its safety in the HIV-infected population has been questioned. Multicentric trials are urgently required to help develop improved diagnostic strategies and formulate shorter, more effective, safe, and evidence-based regimens for treatment and prevention of drugsusceptible and drug-resistant TB.

Item Type:Article
Source:Copyright of this article belongs to University of Chicago Press.
ID Code:110521
Deposited On:01 Sep 2017 09:07
Last Modified:01 Sep 2017 09:07

Repository Staff Only: item control page